Plasma Lipid Composition and Risk of Developing Cardiovascular Disease

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Fernandez, Celine ^a   Sandin, Marianne ^a   Sampaio, Julio L ^b   Almgren, Peter ^a   Narkiewicz, Krzysztof ^c   Hoffmann, Michal ^c   Hedner, Thomas ^d   Wahlstrand, Björn ^d   Simons, Kai ^b   Shevchenko, Andrej ^b   James, Peter ^a   Melander, Olle ^a  

^a LUND UNIVERSITY   (Sweden)

^b MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROPHOSPHOLIPID; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPIDOME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; SPHINGOMYELIN; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID COMPOSITION; LPA GENE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPIDS; MALE; METABOLOME; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PUBLIC HEALTH SURVEILLANCE; RISK; RISK FACTORS;

EID: 84881572704     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071846     Document Type: Article

References (30)

1. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, et al. (2003) Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290: 891-897.
2. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, et al. (2003) Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290: 898-904.
3. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, et al. (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302: 49-57.
4. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, et al. (2006) Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355: 2631-2639.
5. Gross RW, Han X, (2011) Lipidomics at the interface of structure and function in systems biology. Chem Biol 18: 284-291.
6. Han X, Gross RW, (2005) Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 24: 367-412.
7. Sandra K, Pereira Ados S, Vanhoenacker G, David F, Sandra P, (2010) Comprehensive blood plasma lipidomics by liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr A 1217: 4087-4099.
8. Graessler J, Schwudke D, Schwarz PE, Herzog R, Shevchenko A, et al. (2009) Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One 4: e6261.
9. Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, et al. (2011) Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 31: 2723-2732.
10. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, et al. (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121: 1402-1411.
11. Griffiths WJ, Ogundare M, Williams CM, Wang Y, (2011) On the future of "omics": lipidomics. J Inherit Metab Dis 34: 583-592.
12. Fernandez C, Schuhmann K, Herzog R, Fielding B, Frayn K, et al. (2011) Altered desaturation and elongation of fatty acids in hormone-sensitive lipase null mice. PLoS One 6: e21603.
13. Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333-338.
14. Berglund G, Elmstahl S, Janzon L, Larsson SA, (1993) The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 233: 45-51.
15. Persson M, Hedblad B, Nelson JJ, Berglund G, (2007) Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Arterioscler Thromb Vasc Biol 27: 1411-1416.
16. Rosvall M, Janzon L, Berglund G, Engstrom G, Hedblad B, (2005) Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med 257: 430-437.
17. Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, et al. (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 358: 1240-1249.
18. Myocardial Infarction Genetics C, Kathiresan S, Voight BF, Purcell S, Musunuru K, et al. (2009) Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 41: 334-341.
19. Erdmann J, Grosshennig A, Braund PS, Konig IR, Hengstenberg C, et al. (2009) New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 41: 280-282.
20. Ripatti S, Tikkanen E, Orho-Melander M, Havulinna AS, Silander K, et al. (2010) A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 376: 1393-1400.
21. Musunuru K, Orho-Melander M, Caulfield MP, Li S, Salameh WA, et al. (2009) Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol 29: 1975-1980.
22. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P, (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286: 180-187.
23. Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D, (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49: 1137-1146.
24. Herzog R, Schwudke D, Schuhmann K, Sampaio JL, Bornstein SR, et al. (2011) A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language. Genome Biol 12: R8.
25. Storey JD, (2002) A direct approach to false discovery rates. Journal of the Royal Statistical Society Series B-Statistical Methodology 64: 479-498.
26. Quinn MT, Parthasarathy S, Steinberg D, (1988) Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A 85: 2805-2809.
27. Schmitz G, Ruebsaamen K, (2010) Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 208: 10-18.
28. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, et al. (2010) From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466: 714-719.
29. Kai M, Wada I, Imai S, Sakane F, Kanoh H, (1997) Cloning and characterization of two human isozymes of Mg2+-independent phosphatidic acid phosphatase. J Biol Chem 272: 24572-24578.
30. Walkey CJ, Donohue LR, Bronson R, Agellon LB, Vance DE, (1997) Disruption of the murine gene encoding phosphatidylethanolamine N-methyltransferase. Proc Natl Acad Sci U S A 94: 12880-12885.